Cargando…
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped for future pandemics. While unprecedented strides have been made developing vaccines and treatments for COVID-19, there remains a need for highly effective and widely available regimens for ambulatory use for n...
Autores principales: | White, Judith M., Schiffer, Joshua T., Bender Ignacio, Rachel A., Xu, Shuang, Kainov, Denis, Ianevski, Aleksandr, Aittokallio, Tero, Frieman, Matthew, Olinger, Gene G., Polyak, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689562/ https://www.ncbi.nlm.nih.gov/pubmed/34933447 http://dx.doi.org/10.1128/mbio.03347-21 |
Ejemplares similares
-
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
por: Wagoner, Jessica, et al.
Publicado: (2022) -
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020) -
Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)